- Capital Cube•3 months ago
Click here to see latest analysisResponse Biomedical Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of Response Biomedical Corp. – Spectral Medical Inc, Quidel Corporation, Abbott Laboratories, Becton, Dickinson and Company, Meridian Bioscience, Inc. and Thermo Fisher Scientific Inc. (EDTXF-US, QDEL-US, ABT-US, BDX-US, VIVO-US […] (Read more...) The post Response Biomedical Corp. :RPBIF-US: Earnings Analysis: Q1, 2016 By the Numbers : June 9, 2016 appeared first on CapitalCube.
- PR Newswire•3 months ago
TORONTO, May 31, 2016 /CNW/ - DELISTING REVIEW Response Biomedical Corp. (the "Company") – Further to TSX Bulletin 2016-0389 dated April 18, 2016, TSX has decided to extend its review of the ...
Response Biomedical Corp. (RPBIF)
OTC BB - OTC BB Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-6.73|
|Avg Vol (3m)||1,377|
|Dividend & Yield||N/A (N/A)|